JP2021509671A5 - - Google Patents
Info
- Publication number
- JP2021509671A5 JP2021509671A5 JP2020537006A JP2020537006A JP2021509671A5 JP 2021509671 A5 JP2021509671 A5 JP 2021509671A5 JP 2020537006 A JP2020537006 A JP 2020537006A JP 2020537006 A JP2020537006 A JP 2020537006A JP 2021509671 A5 JP2021509671 A5 JP 2021509671A5
- Authority
- JP
- Japan
- Prior art keywords
- neonatal
- glucose
- pharmaceutical composition
- oral pharmaceutical
- clc
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US15/860,966 US10213491B2 (en) | 2015-05-19 | 2018-01-03 | Glucose oxidase compositions as a neonate anticonvulsant |
| US15/860,966 | 2018-01-03 | ||
| PCT/US2019/012208 WO2019136168A1 (en) | 2018-01-03 | 2019-01-03 | Glucose oxidase compositions as a neonate anticonvulsant |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021509671A JP2021509671A (ja) | 2021-04-01 |
| JPWO2019136168A5 JPWO2019136168A5 (https=) | 2022-01-14 |
| JP2021509671A5 true JP2021509671A5 (https=) | 2022-01-14 |
| JP7381469B2 JP7381469B2 (ja) | 2023-11-15 |
Family
ID=67143949
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020537006A Active JP7381469B2 (ja) | 2018-01-03 | 2019-01-03 | 新生児抗痙攣薬としてのグルコースオキシダーゼ組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11666640B2 (https=) |
| EP (1) | EP3735262A4 (https=) |
| JP (1) | JP7381469B2 (https=) |
| CN (1) | CN112105378B (https=) |
| WO (1) | WO2019136168A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111440771A (zh) * | 2020-03-17 | 2020-07-24 | 中山大学附属第三医院 | 一种含有clcn2纯合突变的白质脑病患者特异诱导多能干细胞系 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5364634A (en) | 1991-11-08 | 1994-11-15 | Southwest Research Institute | Controlled-release PH sensitive capsule and adhesive system and method |
| US6020317A (en) | 1993-02-19 | 2000-02-01 | Nippon Shinyaku Co. Ltd. | Glycerol derivative, device and pharmaceutical composition |
| AU7166200A (en) * | 1995-12-27 | 2001-03-08 | Genencor International, Inc. | Process for the preparation of gluconic acid and gluconic acid produced thereby |
| US5994316A (en) | 1996-02-21 | 1999-11-30 | The Immune Response Corporation | Method of preparing polynucleotide-carrier complexes for delivery to cells |
| EP0914096B1 (en) | 1996-05-17 | 2003-08-13 | Elan Drug Delivery Limited | Microparticles and their use in wound therapy |
| US20100029613A1 (en) | 2004-11-15 | 2010-02-04 | University Of Rochester | Treatment and prevention of epilepsy |
| GB0619786D0 (en) * | 2006-10-06 | 2006-11-15 | Inst Of Technology Sligo | An antimicrobial and immunostimulatory system |
| CN101626779B (zh) * | 2007-02-28 | 2012-09-05 | 森永乳业株式会社 | 口腔内用杀菌剂和含有该杀菌剂的食品添加剂 |
| DK2276505T3 (da) | 2008-03-20 | 2013-11-25 | Krister Tano | Næsespray eller næsedråber til behandling af forkølelse |
| WO2012050895A1 (en) | 2010-09-28 | 2012-04-19 | Lisa Geng | Methods for treating neurological disorders using nutrient compositions |
| WO2014165566A1 (en) | 2013-04-03 | 2014-10-09 | Emory University | Hydrophilic particle compositions, processes of production, and uses in dietary management and digestive disorders |
| US20160067190A1 (en) | 2013-04-30 | 2016-03-10 | The Children's Medical Center Corporation | Injectable nano-network gels for diabetes treatment |
| WO2015134490A1 (en) | 2014-03-03 | 2015-09-11 | The Penn State Research Foundation | Self-powered enzyme micropumps |
| CN104450806B (zh) * | 2014-11-27 | 2018-01-16 | 江南大学 | 一种酶法制备葡萄糖酸钠的方法 |
| US10213491B2 (en) | 2015-05-19 | 2019-02-26 | The Penn State Research Foundation | Glucose oxidase compositions as a neonate anticonvulsant |
| US9861597B2 (en) | 2015-05-19 | 2018-01-09 | Penn State Research Foundation | Gluconate-based compositions as a neonate anticonvulsant |
| CN106978451B (zh) * | 2017-03-29 | 2020-04-28 | 华南理工大学 | 一种固定化葡萄糖氧化酶制备葡萄糖酸钠的方法 |
| CN106929500A (zh) * | 2017-04-27 | 2017-07-07 | 南京工业大学 | 葡萄糖氧化酶/过氧化氢酶的交联酶聚体的制备方法及其应用 |
-
2019
- 2019-01-03 EP EP19736175.1A patent/EP3735262A4/en not_active Withdrawn
- 2019-01-03 JP JP2020537006A patent/JP7381469B2/ja active Active
- 2019-01-03 CN CN201980014276.6A patent/CN112105378B/zh active Active
- 2019-01-03 US US16/957,087 patent/US11666640B2/en active Active
- 2019-01-03 WO PCT/US2019/012208 patent/WO2019136168A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2519660C2 (ru) | Режим дозировки селективного агониста рецептора s1p1 | |
| KR20200055067A (ko) | 성인의 초점성 뇌전증의 치료를 위한 합성 경피성 칸나비디올 | |
| EA034940B1 (ru) | Лечение пациентов с сахарным диабетом 2 типа | |
| US20240261242A1 (en) | Methods of intravenously administering sotalol | |
| Holzki et al. | Death after re‐exposure to propofol in a 3‐year‐old child: a case report | |
| Chang et al. | Status epilepticus | |
| JP2025148449A5 (https=) | ||
| JP2021509671A5 (https=) | ||
| US20210330750A1 (en) | Lactate-protected hypoglycemia to treat glycolysis dependent pathological conditions, in particular cancer | |
| CN109172550B (zh) | 一种复合麻醉药物 | |
| JPWO2019136168A5 (https=) | ||
| JP5117230B2 (ja) | 2型糖尿病治療用の併用医薬 | |
| EP4144734A1 (en) | Application of heterocyclic compound | |
| Woehlck et al. | Treatment of refractory mesenteric traction syndrome without cyclooxygenase inhibitors | |
| US20200061053A1 (en) | Pharmaceutical composition and method for acute on chronic liver failure and related liver diseases | |
| Sathaporn et al. | A Rare Cause of Refractory Vasodilatory Shock Due to Calcium Channel Blocker Toxicity from Drug-Drug Interaction Between Ritonavir-Boosted Nirmatrelvir (Paxlovid) And Manidipine | |
| JPWO2022051575A5 (https=) | ||
| US20210177875A1 (en) | Methods and compositions for treating childhood or teen obesity | |
| JP2020143037A (ja) | 糖尿病合併心不全の治療用医薬組成物 | |
| TW202529797A (zh) | Glp-1類似物治療代謝疾病的方法及醫藥用途 | |
| CN105530929B (zh) | 3‑羧基‑n‑乙基‑n,n‑二甲基丙‑1‑铵或其药学上可接受的盐在预防和治疗糖尿病中的用途 | |
| Yousif et al. | A Double-Blind, Randomized Clinical Trial Comparing Sedation Outcomes of Dexmedetomidine and Ketofol in Pediatric Dental Interventions | |
| CN107970248A (zh) | 异甘草酸在制备治疗高血压药物中的用途 | |
| Halpern et al. | Attack cessation and remission induction with 2-bromo-LSD for cluster headache | |
| CN103301115A (zh) | 一种治疗癫痫的药物组合物 |